605507 国邦医药
2026/03 - 三个月
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额193,177559,278706,411516,7611,017,034
投资活动产生之现金流量净额(93,258)(851,459)(513,846)(361,465)(411,764)
筹资活动产生之现金流量净额46,094(122,948)(386,494)(45,936)366,954
汇率变动对现金及现金等价物的影响(7,741)(1,359)27,07610,70635,269
现金及现金等价物净增加/(减少)138,271(416,487)(166,853)120,0661,007,493
期初现金及现金等价物余额1,117,8841,534,3721,701,2251,581,159573,666
期末现金及现金等价物余额1,256,1551,117,8841,534,3721,701,2251,581,159